| abstract |
A method of treating a human suffering from the Syndrome of Type 2 Diabetes. The method includes administering, by a pharmaceutically effective mode, a drug composition including opiates having ยต agonist activity and in particular dihydromorphine, morphine, hydromorphone, methadone, fentanyl, sufentanil, buprenorphine, demorphine, codeine, ethylmorphine, etonitazene, hydrocodone, levorphanol, norcodeine, normophine, oxycodone or loperamide, either alone or in combination with one or more opiates having kappa antagonist activity (more particularly selected from nor-binaltorphine (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2-hydroxy-6,7-benzomorphan (M R 2266), a triethylenedioxy derivative of B-naltrexamine (TENA), and guanidylated naltrindole (GNTI). |